Patient and Public > IR Procedures > Radiofrequency Ablation (RFA)
Search
Print Page
 
 
  Society
  Congress & Meetings
  Patient and Public
  Membership
 
 

Radiofrequency Ablation (RFA)

          
    Liver cancer
 
What is Radiofrequency Ablation?

Radiofrequency ablation (RFA) represents a non-surgical, localised treatment that kills the tumour cells with heat, while sparing the healthy surrounding  tissue.

In this procedure, the interventional radiologist guides a small needle through the skin into the tumour. From the tip of the needle, radiofrequency energy (similar to microwaves) is transmitted to the tip of the needle, where it produces heat in the tissues. The radiofrequency energy delivered to the tumour heats and "burns" the cancerous cells. The dead tumour tissue shrinks and slowly forms a scar.

Because it is a local treatment that does not harm healthy tissue, the treatment can be repeated as often as needed to keep patients comfortable. It is a very safe procedure, with complication rates on the border of two to three percent, and has been available since the late 1990s.

                                                

Click on images to enlarge 

                                                                                                                       Top
Which diseases does Radiofrequency Ablation treat?  


Removal of liver tumours offers the best chance for a cure. Unfortunately, liver tumours are often inoperable because of their localisation or size. Sometimes, many small tumours are spread throughout the liver, making surgery too risky or impractical. Surgical removal is often not possible because the general condition of the patient does not  allow a safe open surgery. For these reason surgical removal of the tumours is not possible for more than two-thirds of primary liver cancer patients and 90 percent of patients with secondary liver cancer.
Historically, chemotherapy drugs have been generally ineffective at curing liver cancer.

Primary liver cancer: most common form is hepatocellular carcinoma (HCC). This is a tumour that begins in the main cells of the liver (hepatocytes). HCC most frequently occurs in those who have a form of liver disease called cirrhosis. Cirrhosis occurs when the liver becomes diseased and develops scarring, usually over a period of years. The liver attempts to repair, or regenerate itself. This process can lead to the formation of tumours. The most common causes of cirrhosis are chronic infection with the liver virus hepatitis B or C and alcohol abuse. The incidence of primary hepatocellular carcinoma is on the rise worldwide, because of the increase of hepatitis C.

Metastatic liver cancer

May spread from any part of the body to the liver. There the cancer cells may grow for months or years before they are detected. One of the most common sources of metastatic liver cancer is from tumours of the colon and rectum. About half of the patients with colon cancer will develop tumours in their liver at some time. About one in 10 of these patients will have a chance for a cure by having the liver tumours removed surgically.


Patients with other types of cancer are also at risk for liver cancer. The liver serves as a way-station for cancer cells that circulate through the bloodstream. These cells may grow and form tumours in the liver. It is estimated that as many as 70 percent of all people with uncontrolled cancer will eventually develop secondary liver tumours, or metastases (tumours formed by primary cancer cells that have spread from other cancer sites).

Radiofrequency Ablation of liver cancer

For inoperable liver tumours RFA offers a non-surgical, localised treatment that kills the tumour cells with heat, while sparing the healthy liver tissue. Thus, this treatment is much easier on the patient than systemic therapy. Radiofrequency energy can be given without affecting the patient's overall health and most people can resume their usual activities in a few days.
In this procedure, the interventional radiologist guides a small needle through the skin into the tumour. From the tip of the needle, radiofrequency energy (similar to microwaves) is transmitted to the tip of the needle, where it produces heat in the tissues. The dead tumour tissue shrinks and slowly forms a scar.

In a small number of cases, RFA can extend patients' lives, but it is generally palliative. Depending on the size of the tumour, RFA can shrink or kill the tumour, extending the patient's survival time and greatly improving their quality of life while living with cancer. Because it is a local treatment that does not harm healthy tissue, the treatment can be repeated as often as needed to keep patients comfortable. It is a very safe procedure, with complication rates on the order of two to three percent, and has been available since the late 1990s.

By decreasing the size of a large mass, or treating new tumours in the liver as they arise, the pain and other debilitating symptoms caused by the tumours are relieved. While the tumours themselves may not be painful, when they press against nerves or interfere with vital organs, they can cause pain. RFA is effective for small to medium-sized tumours and emerging new technologies should allow the treatment of larger cancers in the future.

 
The lung is the most common site for primary cancer worldwide, and smoking tobacco is the leading risk factor. The lung is also a common site of metastases for various malignancies. Metastases occur when a single tumour cell or clump of cells gain access to the blood stream or lymphatic system, travel to a new organ such as the lung, begin to multiply, and then regrow their vascular structure to obtain food.

By the time lung cancer becomes symptomatic, 85 percent of patients are incurable, often due to serious coexisting health conditions or poor respiratory function. Most patients who are diagnosed with non-small cell lung cancer are not surgically resectable at the time of diagnosis. For these patients, minimally invasive interventional radiology procedures can help reduce pain and improve quality of life.  
 
Radiofrequency Ablation of lung cancer

RFA offers a nonsurgical, localised treatment that kills the tumour cells with heat, while sparing nearby healthy lung tissue. Thus, this treatment is much easier on the patient than systemic therapy. Radiofrequency energy can be given without affecting the patient's overall health and most people can resume their usual activities in a few days. It is a safe, minimally invasive tool for local pulmonary tumour control with negligible mortality, little morbidity, short hospital stay, and positive gain in quality of life.
In this procedure, the interventional radiologist guides a small needle through the skin into the tumour. From the tip of the needle, radiofrequency energy (similar to microwaves) is transmitted to the tip of the needle, where it produces heat in the tissues. The dead tumour tissue shrinks and slowly forms a scar. It is ideal for nonsurgical candidates and those with smaller tumours.

Depending on the size of the tumour, RFA can shrink or kill the tumour. Because it is a local treatment that does not harm much healthy tissue, the treatment can be repeated as often as needed to keep patients comfortable. It is a relatively safe procedure, with low complication rates.

By decreasing the size of a large mass, or treating new tumours in the lung as they arise, the pain and other debilitating symptoms caused by the tumours are often relieved. While the tumours themselves may not be painful, when they press against nerves or interfere with vital organs, they can cause pain. RFA is effective for small to medium-sized tumours and emerging new technologies should allow the treatment of larger cancers in the future. RFA is a new treatment that has shown early, promising results, but long-term studies have not yet been completed.

Top

How does Radiofrequency Ablation work?  
 
In this procedure, the interventional radiologist guides a small needle through the skin into the tumour. From the tip of the needle, radiofrequency energy (similar to microwaves) is transmitted to the tip of the needle, where it produces heat in the tissues. The radiofrequency energy delivered to the tumour heat and "burn" the cancerous cells. The dead tumour tissue shrinks and slowly forms a scar.

What are the benefits of Radiofrequency Ablation in treating liver cancer?  
 
Although RFA is not a cure, there are several benefits of its use in the liver:
• Provide a local treatment option when surgery is not possible or too risky
• Usually does not require general anesthesia
• Is well tolerated-most patients can resume their normal routine the next day and may feel tired for a few days
• Can be repeated if necessary
• May be combined with other treatment options
• Shrink larger tumours to a size that makes it possible to remove them surgically or by transplantation.
• Relieve pain and other side effects to reduce suffering and improve the quality of life for people with cancer.
• Treat small tumours in conjunction with surgery of a large mass elsewhere in the liver
• It has a short hospital stay
• It has few complications
What are the risks of Radiofrequency Ablation in treating liver cancer?  
 
RFA is a very safe procedure, with complication rates on the order of two to three percent, and has been available since the late 1990s.
Most frequent complications are pain, fever, pleural effusion. Some cases of bleeding or infections are reported.

What are the risks of Radiofrequency Ablation in treating lung cancer?

RFA is a new treatment that has shown early, promising results, with low complication rates.
Most frequent complications are pain, fever, pleural effusion or pneumothorax. In some cases pneumothorax need to be drained by using a small cathether. Few cases of bleeding or infections are reported.
How should I prepare for Radiofrequency Ablation? 
 
RFA is a relatively easy procedure. You have to be admitted in the hospital and to do some blood tests. In particular the coagulation tests must be in the range of normality.

What does the material for Radiofrequency Ablation look like? 

In this procedure, the interventional radiologist guides a small needle through the skin into the tumour. From the tip of the needle, radiofrequency energy (similar to microwaves) is transmitted to the tip of the needle, where it produces heat in the tissues. The needles can be straight needles or expandable needles with some hooks deploying laterally from the tip in an umbrella or Christmas tree shape.
 
What will I experience during Radiofrequency Ablation? 
 
In this procedure, the interventional radiologist guides a small needle through the skin into the tumour. Local anesthesia, together with mild conscious sedation, will help you not to feel pain. You will possibly sleep during the procedure. At the end of the procedure, you will be awake and recover completely within a few hours.
 
What do I have to do after the procedure? 

After the procedure, you will receive prescriptions for pain. Most RFA procedures can be done as a brief overnight stay. Once home, you may experience pain for one or two days and there may be a low grade fever. Most patients experience few significant side effects beyond these, but depending on the size of the tumour treated and its location, some patients may be fatigued or tired.

You should be able to resume all normal activities within a day or two, depending on how you are feeling. If any symptoms recur or become worse instead of improving, notify your doctor. You will get a follow-up CT or MRI scan, as well as blood tests, to determine how well the RFA worked. CT and MRI scans will continue every three months thereafter to determine how much the tumour ultimately shrunk. RFA frequently may be repeated to treat all lesions or all parts of a larger tumour. Your doctor will keep you apprised of the need for additional treatment.
 
Partly taken from www.sirweb.org
edited by  R. Lencioni
May 2005
                                        
Radiofrequency Ablation (RFA) has good results at controlling the spread of cancer in some patients. RFA typically treats cancers than cannot be removed by surgeons because of their size/location or because the patient is not healthy enough to have open surgery. RFA is primarily used to treat cancer in the liver, but it is nowadays used also to treat cancer in the lung.

• Liver Cancer